SCHEMBL6567902

SCHEMBL6567902

[CH2]CC(c1ccccc1)(c1ccccc1)C1CCCCC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 5/20 0.46
CHRM1 P11229 5/20 0.46
CYP2D6 P10635 4/20 0.46
KCNH2 Q12809 4/20 0.46
CHRM3 P20309 3/20 0.46
CHRM4 P08173 2/20 0.46
CHRM5 P08912 2/20 0.46
GRIN2D O15399 1/20 0.46
GRIN3B O60391 1/20 0.46
HRH1 P35367 1/20 0.46
GRIN1 Q05586 1/20 0.46
GRIN2A Q12879 1/20 0.46
GRIN2B Q13224 1/20 0.46
GRIN2C Q14957 1/20 0.46
GRIN3A Q8TCU5 1/20 0.46
CYP3A4 P08684 1/20 0.46
TSHR P16473 1/20 0.46
NFKB1 P19838 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
HTR1A P08908 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31279338 0.81 CHRM2 (0.46) CHRM2CHRM1CYP2D6KCNH2CHRM3
SCHEMBL1313865 0.77 CHRM2 (0.47) CHRM2CHRM1CYP2D6KCNH2CHRM3
SCHEMBL4540887 0.74 KEAP1 (0.46) CHRM2CHRM1CYP2D6KCNH2CHRM3
SCHEMBL4999651 0.74 CHRM2 (0.44) CHRM2CHRM1CYP2D6KCNH2CHRM3
SCHEMBL1403926 0.71 KEAP1 (0.50) CHRM2CHRM1CYP2D6KCNH2CHRM3
SCHEMBL1385530 0.71 KEAP1 (0.55) CHRM2CHRM1CYP2D6KCNH2CHRM3
SCHEMBL11611734 0.70 CHRM2 (0.44) CHRM2CHRM1CYP2D6KCNH2CHRM3
SCHEMBL6233655 0.69 KEAP1 (0.48) CHRM2CHRM1CYP2D6KCNH2CHRM3
SCHEMBL846064 0.69 KEAP1 (0.48) CHRM2CHRM1CYP2D6KCNH2CHRM3
SCHEMBL5717261 0.69 KEAP1 (0.48) CHRM2CHRM1CYP2D6KCNH2CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1404325-A2 METHOD FOR TREATING NERVE INJURY CAUSED BY SURGERY GUILFORD PHARMACEUTICALS INC. (US) 2004-04-07 EP disclosed
WO-2002096420-A2 METHOD FOR TREATING NERVE INJURY CAUSED BY SURGERY GUILFORD PHARMACEUTICALS INC. (US) 2002-12-05 WO disclosed
EP-1127049-A1 BRIDGED HETEROCYCLIC DERIVATIVES GPI NIL Holdings, Inc. (US) 2001-08-29 EP disclosed
EP-1011650-A1 METHOD FOR PREVENTING AND TREATING HEARING LOSS USING SENSORINEUROTROPHIC COMPOUNDS Amgen Inc., (US) 2000-06-28 EP disclosed
WO-2000016603-A2 BRIDGED HETEROCYCLIC DERIVATIVES GPI NIL HOLDINGS, INC. (US) 2000-03-30 WO disclosed
WO-1999014998-A2 METHOD FOR PREVENTING AND TREATING HEARING LOSS USING SENSORINEUROTROPHIC COMPOUNDS AMGEN INC. (US) 1999-04-01 WO disclosed